Dr. Maria Sabsay Goral, MD

Dr. Goral practices at Backus Hospital in Norwich, Connecticut, part of Hartford HealthCare.

Dr. Goral's NPI, 1063695294, was assigned on December 11, 2007. Dr. Goral holds Connecticut license 047526.

Dr. Goral's primary practice is Backus Hospital, at 326 Washington St, Norwich, CT 06360 in New London County. The practice phone is (860) 889-8331.

Dr. Goral's primary practice is Backus Hospital in Norwich, Connecticut, part of Hartford HealthCare. Dr. Goral is also affiliated with Hartford Hospital. The medical group on file is The William W. Backus Hospital. Dmand AI also links Dr. Goral to 1 more hospital, named with a free account. Dr. Goral's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goral practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Goral's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Goral is licensed in Connecticut.

CMS data shows 711 Medicare services from Dr. Goral across 6 procedure codes in 2024, for 260 Medicare patients. Medicare paid $51,773 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 260 Medicare patients who saw Dr. Goral in 2024. The largest group is 75 to 84, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goral's median patient age at 66, with 52% women.

In 2024, Dr. Goral wrote 418 Medicare Part D claims for 189 patients. 87% of them were for generic drugs. CMS names the drug for 154 of them, across 8 drugs with 11 or more claims each, at $18,173 in total drug cost. In 2023, CMS named 129 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Goral for performance year 2024, reported as part of a group. Dr. Goral accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 139 general payments to Dr. Goral from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $370.